Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 18CNS 1Breast 1

Conditions

Glioma 3Brain Neoplasms 2Prostatic Neoplasms 1Parkinson Disease 1Meningioma 1Glioblastoma 1

Interventions

Radiotherapy 5Magnetic Resonance Spectroscopy 5Docetaxel 5Specimen Handling 4Gemcitabine 3Cyclophosphamide 3temsirolimus 2fludarabine 2Trastuzumab 2Temozolomide 2Sirolimus 2Radiosurgery 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Leucovorin 2Injections 2Fluorouracil 2Fluorodeoxyglucose F18 2Blood Specimen Collection 2Biopsy 2Bevacizumab 2Azacitidine 2vandetanib 1ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Positron Emission Tomography Computed Tomography × CNS × Clear all
NCT06914427 2025-04-06

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Xijing Hospital

Phase NA Not yet recruiting
35 enrolled
CNSGenitourinary

Glioma, Parkinson Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡